Mannkind (MNKD) Other Non-Current Assets (2010 - 2026)
Mannkind (MNKD) reported Other Non-Current Assets of $747000.0 for Q1 2026, down 97.34% year-over-year from $28.1 million in Q1 2025, and down 96.29% quarter-over-quarter from $20.1 million in Q4 2025.
Mannkind (MNKD) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Other Non-Current Assets data on file, last reported at $747000.0 in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $747000.0, down 97.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $747000.0 (down 97.34% YoY), and the FY2025 annual result was $20.1 million, down 24.77% from the prior year.
- Other Non-Current Assets slipped to $747000.0 in Q1 2026 per MNKD's latest filing, from $20.1 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $28.1 million in Q1 2025 and troughed at $732000.0 in Q2 2024.
- A 5-year average of $13.0 million and a median of $12.1 million in 2022 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets surged 2580.87% in 2025, then sank 97.34% in 2026.
- A 5-year view of Other Non-Current Assets shows it stood at $9.7 million in 2022, then dropped by 23.59% to $7.4 million in 2023, then soared by 260.32% to $26.8 million in 2024, then fell by 24.77% to $20.1 million in 2025, then tumbled by 96.29% to $747000.0 in 2026.
- Business Quant data shows MNKD's Other Non-Current Assets at $747000.0 in Q1 2026, $20.1 million in Q4 2025, and $19.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn | 747,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 747,000.00 |
| Dec 31, 2025 | 20.13 Mn |
| Sep 30, 2025 | 19.13 Mn |
| Jun 30, 2025 | 19.62 Mn |
| Mar 31, 2025 | 28.06 Mn |
| Dec 31, 2024 | 26.76 Mn |
| Sep 30, 2024 | 735,000.00 |
| Jun 30, 2024 | 732,000.00 |
| Mar 31, 2024 | 7.45 Mn |
| Dec 31, 2023 | 7.43 Mn |
| Sep 30, 2023 | 8.05 Mn |
| Jun 30, 2023 | 8.35 Mn |
| Mar 31, 2023 | 16.38 Mn |
| Dec 31, 2022 | 9.72 Mn |
| Sep 30, 2022 | 17.31 Mn |
| Jun 30, 2022 | 17.51 Mn |
| Mar 31, 2022 | 12.06 Mn |
| Dec 31, 2021 | 8.44 Mn |
| Sep 30, 2021 | 6.09 Mn |
| Jun 30, 2021 | 5.80 Mn |